160 related articles for article (PubMed ID: 31567954)
21. Primary and Recurrent Focal Segmental Glomerulosclerosis Closely Link to Serum Soluble Urokinase-type Plasminogen Activator Receptor Levels.
Jin J; Li YW; He Q
Transplant Proc; 2015; 47(6):1760-5. PubMed ID: 26293047
[TBL] [Abstract][Full Text] [Related]
22. suPAR and chronic kidney disease-a podocyte story.
Zeier M; Reiser J
Pflugers Arch; 2017 Aug; 469(7-8):1017-1020. PubMed ID: 28689240
[TBL] [Abstract][Full Text] [Related]
23. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
[TBL] [Abstract][Full Text] [Related]
24. Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD.
Böcskei RM; Benczúr B; Losonczy G; Illyés M; Cziráki A; Müller V; Bohács A; Bikov A
Lung; 2019 Apr; 197(2):189-197. PubMed ID: 30820636
[TBL] [Abstract][Full Text] [Related]
25. Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.
Franco Palacios CR; Lieske JC; Wadei HM; Rule AD; Fervenza FC; Voskoboev N; Garovic VD; Zand L; Stegall MD; Cosio FG; Amer H
Transplantation; 2013 Aug; 96(4):394-9. PubMed ID: 23736353
[TBL] [Abstract][Full Text] [Related]
26. Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality.
Zimmermann HW; Reuken PA; Koch A; Bartneck M; Adams DH; Trautwein C; Stallmach A; Tacke F; Bruns T
J Intern Med; 2013 Jul; 274(1):86-100. PubMed ID: 23432143
[TBL] [Abstract][Full Text] [Related]
27. Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea.
Bocskei RM; Meszaros M; Tarnoki AD; Tarnoki DL; Kunos L; Lazar Z; Bikov A
Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32075014
[No Abstract] [Full Text] [Related]
28. Association of Apical Periodontitis with Different Stages of Chronic Kidney Disease Measured by Glomerular Filtration Rate and Systemic Markers: An Observational Study.
Lamba J; Mittal S; Tewari S; Jain D; Tewari S; Duhan J; Sangwan P; Kumar V
J Endod; 2023 Nov; 49(11):1472-1479. PubMed ID: 37640201
[TBL] [Abstract][Full Text] [Related]
29. Plasma levels of soluble urokinase-type plasminogen activator receptor associate with the clinical severity of acute Puumala hantavirus infection.
Outinen TK; Tervo L; Mäkelä S; Huttunen R; Mäenpää N; Huhtala H; Vaheri A; Mustonen J; Aittoniemi J
PLoS One; 2013; 8(8):e71335. PubMed ID: 23990945
[TBL] [Abstract][Full Text] [Related]
30. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis.
Huang J; Liu G; Zhang YM; Cui Z; Wang F; Liu XJ; Chu R; Zhao MH
BMC Med; 2014 May; 12():81. PubMed ID: 24884842
[TBL] [Abstract][Full Text] [Related]
31. Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in ankylosing spondylitis.
Toldi G; Szalay B; Bekő G; Kovács L; Vásárhelyi B; Balog A
Joint Bone Spine; 2013 Jan; 80(1):96-8. PubMed ID: 22999906
[TBL] [Abstract][Full Text] [Related]
32. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality.
Wittenhagen P; Kronborg G; Weis N; Nielsen H; Obel N; Pedersen SS; Eugen-Olsen J
Clin Microbiol Infect; 2004 May; 10(5):409-15. PubMed ID: 15113317
[TBL] [Abstract][Full Text] [Related]
33. A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease.
Wada T; Nangaku M; Maruyama S; Imai E; Shoji K; Kato S; Endo T; Muso E; Kamata K; Yokoyama H; Fujimoto K; Obata Y; Nishino T; Kato H; Uchida S; Sasatomi Y; Saito T; Matsuo S
Kidney Int; 2014 Mar; 85(3):641-8. PubMed ID: 24429394
[TBL] [Abstract][Full Text] [Related]
34. Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD.
AboEl-Magd GH; Mabrouk MM
J Bras Pneumol; 2018; 44(1):36-41. PubMed ID: 29538541
[TBL] [Abstract][Full Text] [Related]
35. Circulating suPAR levels are affected by glomerular filtration rate and proteinuria in primary and secondary glomerulonephritis.
Musetti C; Quaglia M; Cena T; Chiocchetti A; Monti S; Clemente N; Magnani C; Dianzani U; Stratta P
J Nephrol; 2015 Jun; 28(3):299-305. PubMed ID: 25185729
[TBL] [Abstract][Full Text] [Related]
36. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
37. Circulating suPAR as a biomarker of disease severity in children with proteinuric glomerulonephritis.
Sołtysiak J; Zachwieja J; Benedyk A; Lewandowska-Stachowiak M; Nowicki M; Ostalska-Nowicka D
Minerva Pediatr; 2019 Feb; 71(1):4-11. PubMed ID: 27070416
[TBL] [Abstract][Full Text] [Related]
38. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
[TBL] [Abstract][Full Text] [Related]
39. Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients.
Wlazeł RN; Szadkowska I; Bartnicki P; Rośniak-Bąk K; Rysz J
Int Urol Nephrol; 2018 Feb; 50(2):339-345. PubMed ID: 29313168
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers of kidney injury and klotho in patients with atherosclerotic renovascular disease.
Park MY; Herrmann SM; Saad A; Eirin A; Tang H; Lerman A; Textor SC; Lerman LO
Clin J Am Soc Nephrol; 2015 Mar; 10(3):443-51. PubMed ID: 25542906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
